Phase II Proof of Concept Trial of Civamide Patch in the Treatment of Postherpetic Neuraligia.

Trial Profile

Phase II Proof of Concept Trial of Civamide Patch in the Treatment of Postherpetic Neuraligia.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2017

At a glance

  • Drugs Zucapsaicin (Primary)
  • Indications Neuropathic pain; Postherpetic neuralgia
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Winston Laboratories
  • Most Recent Events

    • 17 Nov 2009 According to a Winstone Laoratories media release, based on positive results obtained from this trial, two pivotal phase III trials (see profile 700051244 and 700051245) are planned to be initiated.
    • 17 Nov 2009 Positive, top-line results announced, according to a Winston Laboratories media release.
    • 16 Oct 2009 Planned number of patients changed from 20 to 22 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top